Clinical trial of traditional antihypertensive herb for the management of preeclampsia

CLInical trial of Pear Seeds for the MAnagement of Preeclampsia

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202405559013998

Enrollment

Registered

2024-05-02

Start date

2024-11-25

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Placebo Control

Treatment Group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Provision of consent to participate Pregnancy <6 months Multigravida Presence of preeclampsia with a defined medical management

Exclusion criteria

Exclusion criteria: Unwillingness to participate'' Pregnancy without preeclampsia or pregnancy >6 months Any other pregnancy complications aside preeclampsia Smoking and drinking Primigravida

Design outcomes

Primary

Measure	Time frame
Blood pressure and proteinuria;Birth Weight and Fetal Mortality	—

Secondary

Measure	Time frame
sFLT/PLGF, plasma and placental inflammatory cytokines.	—

Countries

Nigeria

Contacts

Public ContactJustice Osuoha

Lecturer Imo State Polytechnic Umuagwo

Justice_Osuoh@uniport.edu.ng+2348063427117

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026